 |
 |
|
 |
|
|
 |
EKR Therapeutics is a specialty pharmaceutical company, founded in Nov 2005 focusing on identifying, fostering and targeting the growth of products to serve the needs of the acute-care hospital setting. EKR finished the 2008 fiscal year with over $200 million in Gross Revenues and $86 million in EBITDA .The Company is committed to providing this important segment of the healthcare market with novel products to improve patient outcomes and quality of life. |
|
 |
ESP Chinapharma is a specialty pharma company focusing on registration, sales and marketing of pharmaceutical products in China market. It currently has six products in registration in China, and is the distributor of Pharmascience, a leading Canadian pharmaceutical company. |
|
 |
ESP Pharma. A specialty pharmaceutical company founded in 2002, voted Top 100 company by Venture Reporter, reached $ 90MM revenue in 2004, and sold to Protein Design Labs (NASDAQ: PDLI) for more than $ 500 million dollars in January 2005. Protein Design Labs, Inc. (PDL) , a leading developer of humanized monoclonal
antibody drugs. |
|
|
